Reminder to sites: Due to The ICR laboratory Christmas closure days, please do not send blood samples (Biomarker sub study) from the 22nd December 2017 to the 1st January 2018. ...
Have a look below to see the latest STAMPEDE related newsworthy events.
Protocol 17: Updated CRFs
Selective CRFs were updated for the activation of Protocol 17, these were:
- PR08 Form 1: Randomisation form
- PR08 Form 2: Baseline Assessment Forms
- PR08 Form 7: Follow Up Form
- PR08 Form 14: SAE reporting Form
STAMPEDE General Site CRF Training
Please note, training dates are now available for the STAMPEDE General Site CRF training sessions. These sessions are mainly tailored for new staff members at site and any members wanting refresher training.
We will be discussing, how best to complete the CRFs in order to avoid queries, addressing common errors with CRF completion and responding to Data Clarification Forms.
The training dates are as follows:
11th December 2017 (Monday)
3pm – 4.15pm
22nd January 2018 (Monday)
11am – 12.15pm
More training sessions coming up in the new year, dates to be confirmed.
Please register via Eventbrite using the following link:
You can find the slides for the CRF training here.
Further details on how to dial in via WebEx, will be sent out prior to each training sessions taking place.
Eligibility Criteria Reminder
Just a reminder for all sites around the PSA testing eligibility criteria. Please remember that to be eligible for STAMPEDE patients need to have had a pre-treatment PSA test completed within 6 months of the date of randomisation. Please contact the trial management team if you have any queries. ...
The latest results from the Stampede trial in prostate cancer look to confirm a seismic shift in the treatment landscape in favour of Johnson & Johnson’s ageing Zytiga, but the impact for the whole industry – following a study run by academics – could be even more significant.
Check out the latest press, resulting from STAMPEDEs presentations across the European Society for Medical Oncology (ESMO) conference, through the EPVantage link below!